The AI field is continuously advancing rapidly, with several noteworthy developments emerging recently. This article will focus on the open-source plans of Chinese AI company DeepSeek, OpenAIs revenue predictions, and the advancements of AI applications in agriculture and medicine.
DeepSeek plans to open-source part of its code
Chinese AI lab DeepSeek announced its plan to open-source a portion of its online service code during next weeks Open Source Week event. This move aims to enhance transparency and foster collaboration and sharing of AI technology. DeepSeeks strategy reflects the effort of Chinese AI companies to gain trust in international competition through open collaboration.
OpenAI CEO Sam Altman acknowledged on social media that DeepSeeks rise has narrowed OpenAIs technological lead and stated that OpenAI will consider open-sourcing more technologies in the future.
OpenAIs revenue is expected to grow significantly
OpenAIs Chief Financial Officer Sarah Friar stated that the company achieved $1 billion in revenue in 2023 and projected over threefold growth in 2024. She further predicted that OpenAIs revenue could reach $11 billion in 2025. This projection demonstrates OpenAIs enormous potential in commercialization.
Meanwhile, OpenAIs weekly active users surpassed 400 million in February 2025, indicating a rapid increase in the adoption rate of AI tools. OpenAIs inference model developer traffic has doubled in the past six months, and its o3 model has seen a fivefold increase in traffic since its launch in late January.
AI applications in agriculture
Indian Vice President Jagdeep Dhankhar emphasized that artificial intelligence should be utilized to improve agriculture and rural life. The application of AI in agriculture is expected to enhance crop yields, optimize resource utilization, and improve agricultural management, thus promoting sustainable agricultural development.
AI applications in medicine
Research by AI drug development company Insilico Medicine and its collaborators has shown that their lead drug candidate ISM001-055 possesses anti-aging properties, providing a promising therapeutic approach for treating age-related diseases. This finding demonstrates AIs potential in accelerating drug discovery and identifying novel therapies.
Summary
The field of artificial intelligence is in a period of rapid growth. DeepSeeks open-source plans, OpenAIs revenue growth, and the advancements of AI applications in agriculture and medicine all indicate that AI technology will play an increasingly important role in the future.